BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noguchi H, Hirai K, Aoki Y, Sakata K, Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology. 1995;22:1682-1688. [PMID: 7489974 DOI: 10.1002/hep.1840220611] [Cited by in Crossref: 62] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 DuBois B, Mobley D, Chick JFB, Srinivasa RN, Wilcox C, Weintraub J. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis. Clin Imaging. 2019;54:71-77. [PMID: 30553121 DOI: 10.1016/j.clinimag.2018.11.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
2 Dou J, Lou Y, Wu J, Lu Y, Jin Y. Thrombocytopenia in patients with hepatitis B virus-related chronic hepatitis: evaluation of the immature platelet fraction. Platelets. 2014;25:399-404. [PMID: 24047408 DOI: 10.3109/09537104.2013.832742] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
3 Shi B, Zhu H, Liu Y, Lü L, Jin C, Ran L, Zhou K, Yang W, Wang Z, Mei Z. Experimental Studies and Clinical Experiences on Treatment of Secondary Hypersplenism with Extracorporeal High-Intensity Focused Ultrasound. Ultrasound in Medicine & Biology 2012;38:1911-7. [DOI: 10.1016/j.ultrasmedbio.2012.07.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
4 Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic Abnormalities in Cirrhosis and Tumor-Related Portal Vein Thrombosis. Clin Appl Thromb Hemost 2012;18:409-15. [DOI: 10.1177/1076029611427900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
5 McCormick PA, Murphy KM. Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:1009-1031. [PMID: 11139352 DOI: 10.1053/bega.2000.0144] [Cited by in Crossref: 80] [Cited by in F6Publishing: 71] [Article Influence: 4.0] [Reference Citation Analysis]
6 Yamamoto N, Okano K, Oshima M, Akamoto S, Fujiwara M, Tani J, Miyoshi H, Yoneyama H, Masaki T, Suzuki Y. Laparoscopic splenectomy for patients with liver cirrhosis: Improvement of liver function in patients with Child-Pugh class B. Surgery. 2015;158:1538-1544. [PMID: 26070848 DOI: 10.1016/j.surg.2015.05.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
7 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
8 Foruny JR, Blázquez J, Moreno A, Bárcena R, Gil-Grande L, Quereda C, Pérez-Elías MJ, Moreno J, Sánchez J, Muriel A. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. Eur J Gastroenterol Hepatol. 2005;17:1157-1164. [PMID: 16215426 DOI: 10.1097/00042737-200511000-00002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
9 Sezai S, Kamisaka K, Ikegami F, Usuki K, Urabe A, Tahara T, Kato T, Miyazaki H. Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol. 1998;93:80-82. [PMID: 9448180 DOI: 10.1111/j.1572-0241.1998.080_c.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
10 Akahoshi T, Tomikawa M, Kawanaka H, Furusyo N, Kinjo N, Tsutsumi N, Nagao Y, Hayashi J, Hashizume M, Maehara Y. Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. J Gastroenterol Hepatol. 2012;27:286-290. [PMID: 21793908 DOI: 10.1111/j.1440-1746.2011.06870.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
11 Koizumi J, Itou C, Wray R, Myojin K, Hashimoto T, Nagata Y, Yamamuro H, Tsuji T, Ichikawa T, Shiraishi K, Kagawa T, Mine T, Watanabe N, Matsumae M, d’Othée BJ. Partial splenic embolisation using n-butyl cyanoacrylate: intraprocedural evaluation by magnetic resonance imaging. Eur Radiol 2013;23:1429-42. [DOI: 10.1007/s00330-012-2711-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
12 Yongxiang W, Zongfang L, Guowei L, Zongzheng J, Xi C, Tao W. Effects of splenomegaly and splenic macrophage activity in hypersplenism due to cirrhosis. Am J Med. 2002;113:428-431. [PMID: 12401539 DOI: 10.1016/s0002-9343(02)01210-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
13 Ishikawa T, Hamamoto K, Sasaki R, Nishimura T, Matsuda T, Iwamoto T, Takami T, Sakaida I. Significant improvement in portal‐systemic liver failure symptoms and successful management of portal‐splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy. Hepatol Res 2020;50:1201-8. [DOI: 10.1111/hepr.13545] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Stanca C, Fiel M, Aledort L, Cohen E, del Rio Martin J, Schiano T. Factors Associated With Persistent Thrombocytopenia after Liver Transplantation. Transplantation Proceedings 2010;42:1769-73. [DOI: 10.1016/j.transproceed.2010.02.075] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
15 Liu R, Teng XJ, He JF, Xiao SS, Yuan ZB, Li XJ, Gao XS, Zhou BM. Partial splenic embolization using Bletilla striata particles for hypersplenism in cirrhosis: a prospective study. Am J Chin Med. 2011;39:261-269. [PMID: 21476204 DOI: 10.1142/S0192415X11008804] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
16 Chao CP, Nguyen JH, Paz-Fumagalli R, Dougherty MK, Stockland AH. Splenic embolization in liver transplant recipients: early outcomes. Transplant Proc. 2007;39:3194-3198. [PMID: 18089351 DOI: 10.1016/j.transproceed.2007.07.089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tomikawa M, Akahoshi T, Sugimachi K, Ikeda Y, Yoshida K, Tanabe Y, Kawanaka H, Takenaka K, Hashizume M, Maehara Y. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol. 2010;25:397-402. [PMID: 19929930 DOI: 10.1111/j.1440-1746.2009.06031.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
18 Witters P, Freson K, Verslype C, Peerlinck K, Hoylaerts M, Nevens F, Van Geet C, Cassiman D. Review article: Blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029. [PMID: 18331464 DOI: 10.1111/j.1365-2036.2008.03674.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 77] [Article Influence: 7.8] [Reference Citation Analysis]
19 Zhu K, Meng X, Qian J, Huang M, Li Z, Guan S, Jiang Z, Shan H. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients. Dig Liver Dis. 2009;41:411-416. [PMID: 19070555 DOI: 10.1016/j.dld.2008.10.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
20 Osaki A, Suda T, Waguri N, Ishikawa T, Yokoo T, Kamimura K, Tamura Y, Takamura M, Igarashi M, Kawai H, Yamagiwa S, Aoyagi Y. Formula to Predict Platelet Count after Partial Splenic Arterial Embolization in Patients with Hypersplenism. Journal of Vascular and Interventional Radiology 2012;23:900-7. [DOI: 10.1016/j.jvir.2012.03.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
21 Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 66] [Cited by in F6Publishing: 47] [Article Influence: 13.2] [Reference Citation Analysis]
22 Yu SCH, Ho SS, Fung TM, Ip CB, Lam Y, Lau JY. Endovascular Treatment of a Large Fusiform Splenic Artery Aneurysm with a Coaxial Technique Using a 5-F Balloon Catheter and a Microcatheter. Journal of Vascular and Interventional Radiology 2005;16:1373-7. [DOI: 10.1097/01.rvi.0000175335.99014.e4] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
23 Kondo R, Kage M, Ogata T, Nakashima O, Akiba J, Nomura Y, Yano H. Therapeutic efficacy of splenectomy is attenuated by necroinflammation of the liver in patients with liver cirrhosis. J Hepatobiliary Pancreat Sci 2015;22:217-24. [DOI: 10.1002/jhbp.177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Kedia S, Goyal R, Mangla V, Kumar A, Shalimar S, Das P, Pal S, Sahni P, Acharya SK. Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, child's status and institution of specific treatment for hepatitis C with success. Annals of Hepatology 2012;11:921-9. [DOI: 10.1016/s1665-2681(19)31419-x] [Cited by in Crossref: 13] [Article Influence: 1.4] [Reference Citation Analysis]
25 Cai M, Huang W, Lin C, Li Z, Qian J, Huang M, Zeng Z, Huang J, Shan H, Zhu K. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. Eur Radiol 2016;26:370-80. [DOI: 10.1007/s00330-015-3839-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
26 Petermann A, Chabrot P, Cassagnes L, Dumousset E, Alfidja A, Gageanu C, Ravel A, Abergel A, Boyer L. Hypersplenism due to portal hypertension: retrospective evaluation of 17 patients treated by splenic embolization. Diagn Interv Imaging. 2012;93:30-36. [PMID: 22277708 DOI: 10.1016/j.diii.2011.11.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
27 Talwar A, Gabr A, Riaz A, Desai K, Thornburg B, Mouli S, Lewandowski RJ, Salem R. Adverse Events Related to Partial Splenic Embolization for the Treatment of Hypersplenism: A Systematic Review. J Vasc Interv Radiol 2020; 31: 1118-1131. e6. [PMID: 32014400 DOI: 10.1016/j.jvir.2019.08.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
28 Zhu K, Meng X, Li Z, Huang M, Guan S, Jiang Z, Shan H. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study. Eur J Radiol. 2008;66:100-106. [PMID: 17532166 DOI: 10.1016/j.ejrad.2007.04.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
29 Hayashi H, Beppu T, Okabe K, Masuda T, Okabe H, Baba H. Risk factors for complications after partial splenic embolization for liver cirrhosis. Br J Surg. 2008;95:744-750. [PMID: 18412294 DOI: 10.1002/bjs.6081] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 3.9] [Reference Citation Analysis]
30 N’Kontchou G, Seror O, Bourcier V, Mohand D, Ajavon Y, Castera L, Grando-Lemaire V, Ganne-Carrie N, Sellier N, Trinchet JC. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005;17:179-184. [PMID: 15674095 DOI: 10.1097/00042737-200502000-00008] [Cited by in Crossref: 92] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
31 Irie T, Ito K, Ozasa H, Noda Y, Ikeda S, Tanaka S, Arii S, Horikawa S. Splenic artery ligation: A protection against hepatic ischemia/reperfusion injury in partially hepatectomized rats. Hepatol Res 2012;42:819-27. [PMID: 22469310 DOI: 10.1111/j.1872-034X.2012.00989.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Amin MA, El Gendy MM, Dawoud IE, Shoma A, Negm AM, Amer TA. Partial Splenic Embolization Versus Splenectomy for the Management of Hypersplenism in Cirrhotic Patients. World J Surg 2009;33:1702-10. [DOI: 10.1007/s00268-009-0095-2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
33 Elmonem SA, Tantawy HI, Ragheb AS, Matar NE, Tantawi I. The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients. The Egyptian Journal of Radiology and Nuclear Medicine 2011;42:35-42. [DOI: 10.1016/j.ejrnm.2011.01.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
34 Firat A, Boyvat F, Moray G, Aytekin C, Karakayali H, Haberal M. Comparison of two different percutaneous splenic artery interventions in the treatment of hypersplenism: preliminary report. Transplant Proc. 2005;37:1094-1098. [PMID: 15848633 DOI: 10.1016/j.transproceed.2004.12.171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
35 Aref S, Ibrahem L, El Menshawy N, Bassam A. Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia. Hematology 2012;17:118-21. [PMID: 22664051 DOI: 10.1179/102453312X13221316477705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Tanikawa K. Thrombopoietin and liver diseases. Journal of Gastroenterology and Hepatology 2001;15:579-80. [DOI: 10.1046/j.1440-1746.2000.02189.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]